Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > FINANCING REQUIREMENT
View:
Post by 4Justice on Aug 17, 2021 4:52pm

FINANCING REQUIREMENT

From the MD&A page 6

Financial and Other Corporate Impacts

Given that our activities continue to be in the R&D stage, management has concluded we will need additional sources of financing to ensure we have sufficient funds to continue our operations for at least the next 12 months.

Comment by stockbuphoon on Aug 17, 2021 5:01pm
Of course, Thomson could easily give a bridge loan knowing it's a matter of time  before the PRV aid formally approved with all of the antitrust issues BUT THOMSON is purposely not offering it
Comment by RoyaleWithCheez on Aug 17, 2021 5:09pm
Gotta pay for all that administration $$$
Comment by aldo451 on Aug 18, 2021 12:14am
Working hard buddy. Citing standard disclaimer information...lol. Anything to put a negative spin on the PR...what a clown
Comment by 4Justice on Aug 18, 2021 6:47am
It's not a standat disclamer and the clown is the one that didn't read the MD&A and try to convince himself that he knows. Don't louse your time to answer me just go read about YOUR company.
Comment by Damnre on Aug 18, 2021 7:35am
Well all this depends if they received the 72.5m and how fast they expect the money in full before years end and hopefully before q3... financing is reality but they may not need it! Or they can manage to leverage the amount they are waiting from the sell!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities